NLRP3 and cancer: These studies should include diverse patient populations and utilize quantitative PCR or ELISA assays to measure NLRP3 inflammasome activation, aiming to validate their diagnostic accuracy through receiver operating characteristic (ROC) curve analysis for early cancer detection.